Pretreatment with E. faecalis or NLRP3 siRNA has been shown to inhibit NLRP3 inflammasome activation in macrophages and slow the progression of colorectal tumors associated with colitis in mice [36]. The gene discussed is NLRP3; the disease is colitis.